Seized designer supplement named "1-Androsterone": Identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination

Steroids

Volumn 76, Issue 6, 2011, Pages 540-547

  Parr, Maria K ^a   Opfermann, Georg ^a   Geyer, Hans ^a   Westphal, Folker ^b   Sönnichsen, Frank D ^c   Zapp, Josef ^d   Kwiatkowska, Dorota ^e   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b State Bureau of Criminal Investigation Schleswig Holstein   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e Institute of Sport National Research Institute   (Poland)

Author keywords

1 Androsterone; Doping control; GC MS; Metabolism; NMR; Steroid profile

Indexed keywords

1 ANDROSTENE 3BETA OL 17 ONE; 1 ANDROSTENEDIONE; 1 ANDROSTERONE; 1 TESTOSTERONE; 3ALPHA HYDROXY 5ALPHA ANDROST 1 EN 17 ONE; 3BETA HYDROXY 5ALPHA ANDROST 1 EN 17 ONE; 5ALPHA ANDROST 1 EN 3ALPHA,17BETA DIOL; 5ALPHA ANDROST 1 EN 3BETA,17BETA DIOL; ANDROGEN; ANDROST 1 ENE 3,17 DIONE; DRUG METABOLITE; ETIOCHOLANOLONE; LITHIUM DERIVATIVE; LITHIUM TRIS ISOAMYLBOROHYDRIDE; STEROID; UNCLASSIFIED DRUG;

AGED; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG CAPSULE; DRUG ELIMINATION; DRUG LABELING; DRUG SYNTHESIS; GAS CHROMATOGRAPHY; GERMANY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE DRUG DOSE; STEROID URINE LEVEL; VOLUNTEER;

AGED; ANABOLIC AGENTS; ANDROSTANE-3,17-DIOL; ANDROSTERONE; DIETARY SUPPLEMENTS; DIHYDROTESTOSTERONE; ETIOCHOLANOLONE; HUMANS; MALE; SUBSTANCE ABUSE DETECTION; TESTOSTERONE;

EID: 79954626119     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.02.001     Document Type: Article

References (18)

1. US Drug Enforcement Administration. Anabolic steroids control act. US Drug Enforcement Administration; 2004.
2. D.H. Catlin, M.H. Sekera, B.D. Ahrens, B. Starcevic, Y.C. Chang, and C.K. Hatton Tetrahydrogestrinone: discovery, synthesis, and detection in urine Rapid Commun Mass Spectrom 18 2004 1245 1249 (Pubitemid 38843145)
3. M. Parr, H. Geyer, G. Opfermann, and W. Schänzer Prescription drugs and new anabolic steroids in nutritional supplements W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck, Recent advances in doping analysis (12) 2004 Sport und Buch Strauß Köln 71 80
4. M.H. Sekera, B.D. Ahrens, Y.C. Chang, B. Starcevic, C. Georgakopoulos, and D.H. Catlin Another designer steroid: discovery, synthesis, and detection of 'madol' in urine Rapid Commun Mass Spectrom 19 2005 781 784 (Pubitemid 40349418)
5. M.K. Parr, G. Opfermann, and W. Schänzer Detection of new 17-alkylated anabolic steroids on WADA 2006 list W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck, Recent advances in doping analysis (14) 2006 Sport und Buch Strauß Köln 249 258
6. G. Rodchenkov, T. Sobolevsky, and V. Sizoi New designer anabolic steroids from internet W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck, Recent advances in doping analysis (14) 2006 Sport und Buch Strauß Köln 141 150
7. C.A. Reilly, and D.J. Crouch Analysis of the nutritional supplement 1AD, its metabolites, and related endogenous hormones in biological matrices using liquid chromatography-tandem mass spectrometry J Anal Toxicol 28 2004 1 10 (Pubitemid 38112310)
8. L Zhang, Y. Zhang, M. Xie, X. Liu, J. Wang, and Y. Yan Excretion study with different Preparations of 1-Testosterone W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck, Recent advances in doping analysis (14) 2006 Sport und Buch Strauß Köln 179 188
9. M.K. Parr, M. Becker, U. Bartz, G. Opfermann, and W. Schänzer Synthesis of isomers of 5-androstan-17-ol-3-one, androst-1- and -4-ene-3,17-diol and their characterisation with GC/MS DPhG-Jahrestagung 2005 2005 Deutsche Pharmazeutische Gesellschaft Mainz p. 120
10. M. Donike N-Methyll-N-trimethylsilyl-trifluoroacetamide a new silylating agent from series of silylated amides J Chromatogr 42 1969 103
11. H. Geyer, W. Schänzer, U. Mareck-Engelke, E. Nolteernsting, and G. Opfermann Screening procedure for anabolic steroids-control of hydrolysis with deuterated androsterone glucuronide and studies with direct hydrolysis W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke, Recent advances in doping analysis (5) 1998 Köln Sport und Buch Strauss 99 102
12. P. Ciuffreda, S. Casati, and A. Manzocchi Complete H-1 and C-13 NMR spectral assignment of 17-hydroxy epimeric sterols with planar A or A and B rings Magn Reson Chem 42 2004 360 363 (Pubitemid 38822240)
13. W. Schänzer, and M. Donike Metabolism of anabolic-steroids in man - synthesis and use of reference substances for identification of anabolic-steroid metabolites Anal Chim Acta 275 1993 23 48 (Pubitemid 23089847)
14. M.K. Parr, J. Zapp, M. Becker, G. Opfermann, U. Bartz, and W. Schänzer Steroidal isomers with uniform mass spectra of their per-TMS derivatives: synthesis of 17-hydroxyandrostan-3-ones, androst-1-, and -4-ene-3,17-diols Steroids 72 2007 545 551 (Pubitemid 46764792)
15. World Anti-Doping Agency. WADA Technical document TD2003IDCR, 1.2 ed. World Anti-Doping Agency; 2004.
16. M. Donike, M. Ueki, Y. Kuroda, H. Geyer, E. Nolteernsting, and S. Rauth Detection of dihydrotestosterone (DHT) doping: alterations in the steroid profile and reference ranges for DHT and its 5alpha-metabolites J Sport Med Phys Fit 35 1995 235 250 (Pubitemid 26122658)
17. H. Geyer, W. Schänzer, U. Mareck-Engelke, and M. Donike Changes of the urinary steroid profile after sublingual application of dihydrotestosterone M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, Recent advances in doping analysis (3) 1996 Sport und Buch Strauss Köln 215 230
18. World Anti-Doping Agency. The 2010 prohibited list. World Anti-Doping Agency; 2009.